In recent weeks, senior executives from OpenAI have held multiple meetings with the U.S. Food and Drug Administration (FDA) to explore how artificial intelligence could be used in the drug approval process. Central to these discussions is a project called cderGPT, believed to reference the FDA’s Center for Drug Evaluation and Research. According to sources […]